Serotonin and serotonin antagonism in cardiovascular and non‐cardiovascular disease

WH Frishman, S Huberfeld, S Okin… - The Journal of …, 1995 - Wiley Online Library
Serotonin, or 5‐hydroxytryptamine, is a naturally‐occurring vasoactive substance found
primarily in the brain, enterochromaffin tissue, and blood platelets. It has diffuse …

Serotonin and the heart

WH Frishman, P Grewall - Annals of medicine, 2000 - Taylor & Francis
Serotonin is a naturally occurring vasoactive substance that has diverse cardio-
physiological effects. These effects can be explained by the existence of serotonin receptor …

Serotoninergic mechanisms in hypertension. Focus on the effects of ketanserin.

P Vanhoutte, A Amery, W Birkenhäger… - …, 1988 - Am Heart Assoc
Aggregating platelets release serotonin, which induces contraction of most vascular smooth
muscle by activation of S2-serotoninergic receptors. Serotonin released in the circulation …

Cardiovascular effects of serotonin

PM Vanhoutte - Journal of cardiovascular pharmacology, 1987 - journals.lww.com
The major target for circulating serotonin (released from aggregating platelets) appears to
be the blood vessel wall (although little evidence is available), suggesting a role for the …

Serotonin and the vascular system: role in health and disease, and implications for therapy

DS Houston, PM Vanhoutte - Drugs, 1986 - Springer
Serotonin released from aggregating platelets can reach sufficient concentrations to affect
local vascular function in a number of ways. The monoamine can cause contraction of blood …

Serotonin (5Ht) and its antagonists: involvement in the cardiov ascular system

JF Marwood, GS Stokes - Clinical and experimental …, 1984 - Wiley Online Library
The cardiovascular actions of serotonin and its antagonists are reviewed with a view to
clarifying whether serotonin has a role in blood pressure control through actions on the …

Serotonin and the heart: effects of ketanserin on myocardial function, heart rate, and arrhythmias

S Saman, F Thandroyen, LH Opie - Journal of Cardiovascular …, 1985 - journals.lww.com
Serotonergic receptors have been identified in the blood vessels of the heart and in
myocardial tissue. We indirectly examined the potential significance of these receptors by …

Serotonin agonists and antagonists in experimental hypertension

PR Saxena, GR Bolt, KM Dhasmana - Journal of cardiovascular …, 1987 - journals.lww.com
Abstract Serotonin (5-hydroxytryptamine; also called 5-HT) modifies cardiovascular activity
by central as well as peripheral sites of action. When 5-HT is injected within the central …

Direct and sensitizing effects of serotonin agonists and antagonists on vascular smooth muscle

JH Myers, TE Mecca, RC Webb - Journal of cardiovascular …, 1985 - journals.lww.com
Serotonin has several effects on vascular smooth muscle. In most vascular beds it causes
vasoconstriction, but under the proper conditions it can cause vasodilatation. The constrictor …

Augmentation of vasoconstrictor responses to serotonin by acute and chronic factors: inhibition by ketanserin.

JM Van Nueten, WJ Janssens - Journal of hypertension …, 1986 - europepmc.org
Serotonin induces constrictor responses on smooth muscle tissues from several vascular
regions mainly by its interaction with serotonin-S2 receptor sites. The individual sensitivity of …